癌症来了两次,她赢了两次!如何避免再次得癌?医生指出2个关键

2020-09-13 39健康网 39健康网

一大早,粉丝@大尾巴鱼 来信: 小艾,为什么人得了一次癌症后,还会再次得癌?我爸爸去年得了肺癌,这出院不到一年,上个月又查出胆囊癌,为什么癌症患者治愈后不会有抗癌?得了一次癌症,如何才能避免下次再得癌

一大早,粉丝@大尾巴鱼 来信:

小艾,为什么人得了一次癌症后,还会再次得癌?我爸爸去年得了肺癌,这出院不到一年,上个月又查出胆囊癌,为什么癌症患者治愈后不会有抗癌?得了一次癌症,如何才能避免下次再得癌?

癌症来了两次,她赢了两次

作为一个彻底的女权主义者,苏珊·桑塔格在文艺青年的心目中影响很大,不过很多人可能不知道的是,这个学术巨子生前曾两次患癌。

1975年,刚过不惑之年的她被查出是乳腺癌,而且还是晚期。那个时候的乳腺癌对女性的威胁很大,因为相比现在,当时的医疗技术还不是太先进。不过在儿子的劝说之下,苏珊选择积极治疗。她被迫切除了一个乳房,并且使用了刚获得临床应用不久的化疗药物阿霉素。

效果虽然不错,但是副作用让其承受了太大的痛苦,她终于知道癌症治疗的过程就是放大人心理和生理上各种负面的过程。不过幸运的是,到1978年,医生告诉她可能治愈了。

一晃20年过去了,到了1998年,年近古稀的苏珊又被确诊为子宫癌。她依旧没有放弃,用承受极度痛苦的过程为代价第二次战胜了癌症。

直到2004年,苏珊因为白血病而去世。

人得了一次癌症后,还会得别的癌症吗?

得了癌症后再次得癌,这种情况在临床上并不少见,这被称为二次原发肿瘤。不同的是,癌症治疗后存在复发和转移,而二次原发肿瘤不是复发转移,而是在身体的其他部位,出现的新的肿瘤。

二次原发肿瘤的位置可以是身体的任何地方,但它本身的构成却跟第一次的肿瘤没有任何的关系。就像苏珊·桑塔格这样,她就是典型的二次原发肿瘤。临床上虽然不是太罕见,不过相对于复发和转移,二次肿瘤的致病机理在很多层面还不被临床所熟知。

癌症患者再次患癌是普通人的11倍

临床上,二次原发肿瘤的发病几率比健康人群高出11倍,第一次的治疗方式、生活习惯以及遗传因素等多种原因,都影响着二次肿瘤的产生。对于肿瘤本身的治疗,药物的相互作用以及对身体的影响,整个过程就是复杂的。

医学上,很多时候只能窥一斑而见全豹,但对于其后产生的很多连带效应,却往往顾及不到。比如治疗乳腺癌的药物他莫昔芬,会导致子宫内膜增厚,长期的服用该药,会增加患子宫内膜癌的风险。但是在治疗乳腺癌的过程中,不能因为其副作用而放弃使用该药。同样,在其他治疗癌症的用药中,也存在类似现象。

除了治疗本身因素之外,生活习惯也会影响患者接下来的健康和预后。有些癌症本身就是因为一些不良因素导致的,如果癌症治愈了,但是致病因素没有消除,那么疾病很有可能还会卷土重来。至于遗传因素的影响,目前医学界更没有技术进行干预。

所以,二次原发肿瘤的发生,虽然是新的肿瘤疾病,但其实仍可看作是新疾病的延伸。

哪些人容易二次患癌,如何预防

临床统计显示,美国在近20年的时间里,超过8%的癌症患者有过二次原发肿瘤的发生。在各类癌症中,二次原发肿瘤最高的是肺癌,达到了18%;结肠癌达到了12%;而前列腺癌和膀胱癌分别是9%和8%。

相比之下,二次原发肿瘤的致死率非常高,一半以上的患者都是因为二次原发肿瘤而去世。

虽然二次原发肿瘤的发生很凶险,但是尽早发现和治疗也不是没有治愈的可能。

首先就要定期复查。有一位癌症患者,先后患过三次肿瘤,先是结肠癌,后来又是肝癌,最后又是肺癌。不过幸好每次发现的都比较早,因此能够及时治疗。

其实对于已经得过癌症的患者来说,治愈后体检的次数肯定要高于普通人,那么这也能够尽早发现二次原发肿瘤的产生。

除了定期的体检复查外,另一个老生常谈的问题就是保持健康的生活习惯,只有最大可能的剔除一些致病因素,才能最大限度保证身体健康。

癌症凶猛,不过公众应该保持定力和恒心,有坚持下去的勇气,才能产生抗争的爆发力。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=885187, encodeId=5d0c88518e98, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc745415211, createdName=戴小姐, createdTime=Mon Sep 14 16:10:11 CST 2020, time=2020-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=885623, encodeId=e6d48856232e, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=64245268311, createdName=14818eb4m67暂无昵称, createdTime=Wed Sep 16 08:08:43 CST 2020, time=2020-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=885321, encodeId=440788532192, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Mon Sep 14 23:39:46 CST 2020, time=2020-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=885196, encodeId=08b0885196d9, content=收藏, beContent=null, objectType=article, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201009/850075858cc4481aa22c247c691bc9b6/4a0a2f141a844cb2a0af4d9ae3c281b1.jpg, createdBy=10bd2163613, createdName=12038f64m02暂无昵称, createdTime=Mon Sep 14 16:27:59 CST 2020, time=2020-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=885044, encodeId=a3f28850448a, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/bclnHdXwNdCRck1icZt5ez4XdZBbd3bnibaR05oUIZgEd3cWNPYTIAk61KmOhbnZC5gww9muYicafeYicGasc6cKgw/132, createdBy=a56a5273118, createdName=宋秋怡, createdTime=Sun Sep 13 22:42:19 CST 2020, time=2020-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=885030, encodeId=ac128850306f, content=阅读, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3282551952, createdName=12543f43m99暂无昵称, createdTime=Sun Sep 13 22:07:03 CST 2020, time=2020-09-13, status=1, ipAttribution=)]
    2020-09-14 戴小姐

    学习了

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=885187, encodeId=5d0c88518e98, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc745415211, createdName=戴小姐, createdTime=Mon Sep 14 16:10:11 CST 2020, time=2020-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=885623, encodeId=e6d48856232e, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=64245268311, createdName=14818eb4m67暂无昵称, createdTime=Wed Sep 16 08:08:43 CST 2020, time=2020-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=885321, encodeId=440788532192, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Mon Sep 14 23:39:46 CST 2020, time=2020-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=885196, encodeId=08b0885196d9, content=收藏, beContent=null, objectType=article, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201009/850075858cc4481aa22c247c691bc9b6/4a0a2f141a844cb2a0af4d9ae3c281b1.jpg, createdBy=10bd2163613, createdName=12038f64m02暂无昵称, createdTime=Mon Sep 14 16:27:59 CST 2020, time=2020-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=885044, encodeId=a3f28850448a, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/bclnHdXwNdCRck1icZt5ez4XdZBbd3bnibaR05oUIZgEd3cWNPYTIAk61KmOhbnZC5gww9muYicafeYicGasc6cKgw/132, createdBy=a56a5273118, createdName=宋秋怡, createdTime=Sun Sep 13 22:42:19 CST 2020, time=2020-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=885030, encodeId=ac128850306f, content=阅读, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3282551952, createdName=12543f43m99暂无昵称, createdTime=Sun Sep 13 22:07:03 CST 2020, time=2020-09-13, status=1, ipAttribution=)]
    2020-09-16 14818eb4m67暂无昵称

    学习

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=885187, encodeId=5d0c88518e98, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc745415211, createdName=戴小姐, createdTime=Mon Sep 14 16:10:11 CST 2020, time=2020-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=885623, encodeId=e6d48856232e, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=64245268311, createdName=14818eb4m67暂无昵称, createdTime=Wed Sep 16 08:08:43 CST 2020, time=2020-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=885321, encodeId=440788532192, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Mon Sep 14 23:39:46 CST 2020, time=2020-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=885196, encodeId=08b0885196d9, content=收藏, beContent=null, objectType=article, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201009/850075858cc4481aa22c247c691bc9b6/4a0a2f141a844cb2a0af4d9ae3c281b1.jpg, createdBy=10bd2163613, createdName=12038f64m02暂无昵称, createdTime=Mon Sep 14 16:27:59 CST 2020, time=2020-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=885044, encodeId=a3f28850448a, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/bclnHdXwNdCRck1icZt5ez4XdZBbd3bnibaR05oUIZgEd3cWNPYTIAk61KmOhbnZC5gww9muYicafeYicGasc6cKgw/132, createdBy=a56a5273118, createdName=宋秋怡, createdTime=Sun Sep 13 22:42:19 CST 2020, time=2020-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=885030, encodeId=ac128850306f, content=阅读, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3282551952, createdName=12543f43m99暂无昵称, createdTime=Sun Sep 13 22:07:03 CST 2020, time=2020-09-13, status=1, ipAttribution=)]
    2020-09-14 1209e435m98(暂无昵称)

    学习了,谢谢分享

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=885187, encodeId=5d0c88518e98, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc745415211, createdName=戴小姐, createdTime=Mon Sep 14 16:10:11 CST 2020, time=2020-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=885623, encodeId=e6d48856232e, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=64245268311, createdName=14818eb4m67暂无昵称, createdTime=Wed Sep 16 08:08:43 CST 2020, time=2020-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=885321, encodeId=440788532192, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Mon Sep 14 23:39:46 CST 2020, time=2020-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=885196, encodeId=08b0885196d9, content=收藏, beContent=null, objectType=article, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201009/850075858cc4481aa22c247c691bc9b6/4a0a2f141a844cb2a0af4d9ae3c281b1.jpg, createdBy=10bd2163613, createdName=12038f64m02暂无昵称, createdTime=Mon Sep 14 16:27:59 CST 2020, time=2020-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=885044, encodeId=a3f28850448a, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/bclnHdXwNdCRck1icZt5ez4XdZBbd3bnibaR05oUIZgEd3cWNPYTIAk61KmOhbnZC5gww9muYicafeYicGasc6cKgw/132, createdBy=a56a5273118, createdName=宋秋怡, createdTime=Sun Sep 13 22:42:19 CST 2020, time=2020-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=885030, encodeId=ac128850306f, content=阅读, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3282551952, createdName=12543f43m99暂无昵称, createdTime=Sun Sep 13 22:07:03 CST 2020, time=2020-09-13, status=1, ipAttribution=)]
    2020-09-14 12038f64m02暂无昵称

    收藏

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=885187, encodeId=5d0c88518e98, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc745415211, createdName=戴小姐, createdTime=Mon Sep 14 16:10:11 CST 2020, time=2020-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=885623, encodeId=e6d48856232e, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=64245268311, createdName=14818eb4m67暂无昵称, createdTime=Wed Sep 16 08:08:43 CST 2020, time=2020-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=885321, encodeId=440788532192, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Mon Sep 14 23:39:46 CST 2020, time=2020-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=885196, encodeId=08b0885196d9, content=收藏, beContent=null, objectType=article, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201009/850075858cc4481aa22c247c691bc9b6/4a0a2f141a844cb2a0af4d9ae3c281b1.jpg, createdBy=10bd2163613, createdName=12038f64m02暂无昵称, createdTime=Mon Sep 14 16:27:59 CST 2020, time=2020-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=885044, encodeId=a3f28850448a, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/bclnHdXwNdCRck1icZt5ez4XdZBbd3bnibaR05oUIZgEd3cWNPYTIAk61KmOhbnZC5gww9muYicafeYicGasc6cKgw/132, createdBy=a56a5273118, createdName=宋秋怡, createdTime=Sun Sep 13 22:42:19 CST 2020, time=2020-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=885030, encodeId=ac128850306f, content=阅读, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3282551952, createdName=12543f43m99暂无昵称, createdTime=Sun Sep 13 22:07:03 CST 2020, time=2020-09-13, status=1, ipAttribution=)]
    2020-09-13 宋秋怡

    学习了

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=885187, encodeId=5d0c88518e98, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc745415211, createdName=戴小姐, createdTime=Mon Sep 14 16:10:11 CST 2020, time=2020-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=885623, encodeId=e6d48856232e, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=64245268311, createdName=14818eb4m67暂无昵称, createdTime=Wed Sep 16 08:08:43 CST 2020, time=2020-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=885321, encodeId=440788532192, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Mon Sep 14 23:39:46 CST 2020, time=2020-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=885196, encodeId=08b0885196d9, content=收藏, beContent=null, objectType=article, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201009/850075858cc4481aa22c247c691bc9b6/4a0a2f141a844cb2a0af4d9ae3c281b1.jpg, createdBy=10bd2163613, createdName=12038f64m02暂无昵称, createdTime=Mon Sep 14 16:27:59 CST 2020, time=2020-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=885044, encodeId=a3f28850448a, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/bclnHdXwNdCRck1icZt5ez4XdZBbd3bnibaR05oUIZgEd3cWNPYTIAk61KmOhbnZC5gww9muYicafeYicGasc6cKgw/132, createdBy=a56a5273118, createdName=宋秋怡, createdTime=Sun Sep 13 22:42:19 CST 2020, time=2020-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=885030, encodeId=ac128850306f, content=阅读, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3282551952, createdName=12543f43m99暂无昵称, createdTime=Sun Sep 13 22:07:03 CST 2020, time=2020-09-13, status=1, ipAttribution=)]
    2020-09-13 12543f43m99暂无昵称

    阅读

    0

相关资讯

npj Precision Oncology:神奇!小蜜蜂的毒液有大用处,体外实验中可100%杀死癌细胞

蜂毒是蜜蜂和马蜂等蜂类毒腺分泌的有毒液体,其主要成分是由26个氨基酸残基组成的蜂毒肽,这是目前人类所知抗炎性最强的物质之一,在抑菌、抗辐射、抗病毒等方面具有显着疗效。

Nat Rev Cancer:迄今全面癌症驱动基因全景图,66种癌症中的568个致癌基因汇总

癌症是一大类疾病,其特征在于基因组中的突变或其他改变导致细胞生长不受控制。肿瘤可出现数百至数千个突变,但只有少数几个对其致瘤能力至关重要。这些关键突变影响癌症驱动基因的功能。

Nature:癌细胞通过争夺蛋氨酸躲过免疫系统追杀,邹伟平教授提出“剥夺蛋氨酸,饿死癌细胞”策略

肿瘤细胞通过高表达蛋氨酸转运蛋白SLC43A2来疯狂消耗蛋氨酸,从而竞争性地使T细胞无法获得蛋氨酸。这项研究确定了肿瘤微环境中蛋氨酸代谢、组蛋白修饰和T细胞免疫之间的机制联系。

Nature:科学家找到让癌细胞“消停”的关键——TRIM37或是细胞分裂的“变阻器”

人体内时刻有细胞在分裂,在这个过程中出现的不受控制的错误会助长遗传错误,并可能继续发展为癌细胞。自100多年前癌细胞被发现以来,科学家们一直尝试寻找能够消灭这些“有害”细胞、治愈癌症的方法。

Nature:终于知道癌细胞为啥那么“豪横”了,原来是它们更能“抢食”

密歇根大学的一支研究团队指出,一种称为蛋氨酸的氨基酸对T细胞的活力和功能影响最大,由于肿瘤细胞比T细胞更擅长“夺取”这种营养物质,造成T细胞中蛋氨酸含量较低,进而改变了组蛋白的修饰模式。

北京癌症防治学会食管癌专委会成立,引领中国食管癌诊疗进入新阶段

今日(9月6日),为促进全国食管癌多个领域的权威专家共同探索、交流,引领我国食管癌综合诊疗水平进入新的阶段,北京癌症防治学会今日正式宣布成立北京癌症防治学会食管癌专业委员会,并于北京召开以 &ldqu